Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Clinical trial NCT05018975 · WITHDRAWN

Trial details

NCT number: NCT05018975
Sponsor: Loma Linda University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome Cytokine Release Syndrome

Start date: 2022-01-01
Primary completion: 2023-09-21
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.